Mangrove Partners’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-100,000
Closed -$975K 522
2021
Q4
$975K Hold
100,000
0.06% 432
2021
Q3
$970K Hold
100,000
0.09% 300
2021
Q2
$974K Buy
+100,000
New +$979K 0.1% 236

Other funds holding AONC

Mangrove Partners's AONC Position: Q1 2022 in Review

Mangrove Partners sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2022, closing a stake of 100,000 shares — an estimated $975K sold.

Mangrove Partners first reported a position in AONC in Q2 2021 and held it in 3 quarters. The position peaked at $975K in Q4 2021. 65 funds tracked by Wall St. Rank hold AONC as of Q1 2022.

  • Mangrove Partners reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2022 after selling out during the quarter.
  • Mangrove Partners sold 100,000 American Oncology Network, Inc. Class A Common Stock shares in Q1 2022, an estimated $975K.
  • Mangrove Partners first reported a position in American Oncology Network, Inc. Class A Common Stock in Q2 2021 and held it in 3 quarters.
  • Mangrove Partners's American Oncology Network, Inc. Class A Common Stock position peaked at $975K in Q4 2021.
  • 65 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2022.

Based on Mangrove Partners's 13F filing for Q1 2022, filed 16 May 2022.